Multiple Testing Problems in Pharmaceutical Statistics by Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz

By Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz

Valuable Statistical methods for Addressing Multiplicity IssuesIncludes functional examples from fresh trials Bringing jointly major statisticians, scientists, and clinicians from the pharmaceutical undefined, academia, and regulatory organisations, a number of checking out difficulties in Pharmaceutical statistics explores the swiftly starting to be zone of a number of comparability study with an emphasis on pharmaceutical purposes. In every one bankruptcy, the specialist individuals describe vital multiplicity difficulties encountered in pre-clinical and scientific trial settings. The ebook starts with a extensive advent from a regulatory standpoint to kinds of multiplicity difficulties that often come up in confirmatory managed medical trials, ahead of giving an outline of the recommendations, rules, and techniques of a number of trying out. It then provides statistical tools for reading medical dose reaction reviews that evaluate numerous dose degrees with a keep an eye on in addition to statistical equipment for studying a number of endpoints in medical trials. After overlaying gatekeeping systems for trying out hierarchically ordered hypotheses, the booklet discusses statistical ways for the layout and research of adaptive designs and comparable confirmatory speculation checking out difficulties. the ultimate bankruptcy specializes in the layout of pharmacogenomic stories in accordance with confirmed statistical ideas. It additionally describes the research of information accrued in those stories, bearing in mind the varied multiplicity concerns that take place. This quantity explains how one can resolve severe concerns in a number of checking out encountered in pre-clinical and medical trial functions. It offers the mandatory statistical technique, besides examples and software program code to teach tips to use the equipment in perform.

Show description

Read Online or Download Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall CRC Biostatistics Series) PDF

Best biostatistics books

Statistical Tools for Nonlinear Regression: A Practical Guide with S-PLUS and R Examples

This publication offers tools for interpreting information utilizing parametric nonlinear regression types. utilizing examples from experiments in agronomy and biochemistry, it indicates how one can follow the tools. geared toward scientists who're now not conversant in statistical concept, it concentrates on featuring the equipment in an intuitive approach instead of constructing the theoretical grounds.

Social Inequalities and Cancer

There's transparent facts from industrialized and less-developed societies that melanoma prevalence and survival are relating to socioeconomic elements. This interesting quantity, the 1st to ascertain the importance of those socioeconomic variations with regards to melanoma, offers very important info for all these drawn to the connection among public overall healthiness and oncology.

Analyzing Microarray Gene Expression Data (Wiley Series in Probability and Statistics)

A multi-discipline, hands-on advisor to microarray research of organic processesAnalyzing Microarray Gene Expression facts offers a accomplished evaluation of obtainable methodologies for the research of information derived from the most recent DNA microarray applied sciences. Designed for biostatisticians coming into the sphere of microarray research in addition to biologists trying to extra successfully research their very own experimental info, the textual content incorporates a distinct interdisciplinary technique and a mixed educational and useful point of view that provides readers the main whole and utilized insurance of the subject material so far.

Some Mathematical Models from Population Genetics: École d'Été de Probabilités de Saint-Flour XXXIX-2009

This paintings displays 16 hours of lectures brought via the writer on the 2009 St Flour summer season institution in chance. It offers a fast advent to a variety of mathematical types that experience their origins in theoretical inhabitants genetics. The versions fall into sessions: forwards in time types for the evolution of frequencies of alternative genetic kinds in a inhabitants; and backwards in time (coalescent) types that hint out the genealogical relationships among members in a pattern from the inhabitants.

Additional resources for Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall CRC Biostatistics Series)

Sample text

Therefore, statistical analysis of a composite endpoint generally includes some sort of analysis for its components. This raises multiplicity issues. , one tests for the composite endpoint first and then for its components. However, the multiplicity adjustment strategy for the components, depend- © 2010 by Taylor and Francis Group, LLC Multiplicity Problems in Clinical Trials: A Regulatory Perspective 27 ing on the objectives of the trial, can vary. It can vary from no adjustment for the analysis of components to adjustments to control the FWER in the strong sense.

The sample size and design considerations of trials with this focus, and also the trial conduct rules and interpretation of results, are quite different than superiority trials. In addition, the determination of assay sensitivity and the non-inferiority margin can be quite complex and challenging. , two-arm trials with multiple endpoints or single-endpoint trials with multiple doses or subgroup analyses. , multiple treatment arms, multiple endpoints and tests for non-inferiority and superiority.

2002) and Senn (1994) provided useful comments and recommendations on this matter. 5 Multiplicity in the analysis of safety endpoints This section includes some basic concepts and general framework for analysis of multiple safety endpoints. Safety evaluation of a treatment or an intervention intended for the treatment of a disease is an important objective of all clinical trials in general. For this reason, clinical trials collect adverse events (AEs) data for each patient of the trial along with other relevant information that help in clinical evaluation as well as quantitative analysis of these events.

Download PDF sample

Rated 4.43 of 5 – based on 27 votes